arrow
P

Peter G. Miller

broad institute
H指数:33
被引数:4,862

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis

OGFOD1通过调控蛋白质合成使急性髓系白血病(AML)具有化疗和营养应激抗性。

2025-09-160
PRE
Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platform

使用集成药物发现平台鉴定PPM1D小分子抑制剂

2025-02-010
OAAI
Modulating mRNA Translation Fidelity As a Novel Mechanism for AML Chemoresistance

调节mRNA翻译保真度作为一种AML化疗耐药的新机制

BLOOD
IF23.1
2024-11-050
PRE
Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy
2024-10-231
PRE
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation (vol 30, pg 1503, 2023)
2024-02-010
OA
Clonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function
2023-12-015
PRE
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
2023-08-0121
OAAI
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
2023-04-126
OA
Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study
2023-03-010
PRE
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells
2022-08-1526
OAAI
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state
2022-06-3017
OAAI
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation

PPM1D突变是从头弥漫性中线胶质瘤形成的致癌驱动因素

2022-02-0127
OAAI